| (-)-epigallocatechin 3-gallate | multiple interactions | ISO | RGD:1314075 | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of TFDP2 mRNA | CTD | PMID:22079256 |
| 17alpha-ethynylestradiol | decreases expression | ISO | RGD:1314075 | 6480464 | Ethinyl Estradiol results in decreased expression of TFDP2 mRNA | CTD | PMID:18936297 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:1314075 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of TFDP2 mRNA | CTD | PMID:12377990 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:1552301 | 6480464 | Tetrachlorodibenzodioxin affects the expression of TFDP2 mRNA | CTD | PMID:21570461 |
| 2-butoxyethanol | increases expression | ISO | RGD:1552301 | 6480464 | n-butoxyethanol results in increased expression of TFDP2 mRNA | CTD | PMID:19812364 |
| 4-hydroxynon-2-enal | decreases expression | ISO | RGD:1314075 | 6480464 | 4-hydroxy-2-nonenal results in decreased expression of TFDP2 mRNA | CTD | PMID:12419474 |
| all-trans-retinoic acid | decreases expression | ISO | RGD:1314075 | 6480464 | Tretinoin results in decreased expression of TFDP2 mRNA | CTD | PMID:16129123 |
| all-trans-retinoic acid | decreases expression | ISO | RGD:1314075 | 6480464 | Tretinoin results in decreased expression of TFDP2 mRNA | CTD | PMID:16129123 PMID:15498508 |
| all-trans-retinoic acid | decreases expression | ISO | RGD:1314075 | 6480464 | Tretinoin results in decreased expression of TFDP2 mRNA | CTD | PMID:15498508 PMID:16129123 |
| arsenic atom | increases expression | ISO | RGD:1314075 | 6480464 | Arsenic results in increased expression of TFDP2 mRNA | CTD | PMID:11134558 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:1552301 | 6480464 | [Benzo(a)pyrene co-treated with XPA gene mutant form co-treated with TRP53 gene mutant form] results in decreased expression of TFDP2 mRNA | CTD | PMID:21715664 |
| benzo[a]pyrene | decreases expression | ISO | RGD:1314075 | 6480464 | Benzo(a)pyrene results in decreased expression of TFDP2 mRNA | CTD | PMID:20106945 PMID:21632981 |
| benzo[a]pyrene | decreases expression | ISO | RGD:1552301 | 6480464 | Benzo(a)pyrene results in decreased expression of TFDP2 mRNA | CTD | PMID:21715664 |
| benzo[a]pyrene | decreases expression | ISO | RGD:1314075 | 6480464 | Benzo(a)pyrene results in decreased expression of TFDP2 mRNA | CTD | PMID:20106945 |
| cadmium dichloride | increases expression | ISO | RGD:1314075 | 6480464 | Cadmium Chloride results in increased expression of TFDP2 mRNA | CTD | PMID:12160620 |
| calcitriol | decreases expression | ISO | RGD:1314075 | 6480464 | Calcitriol results in decreased expression of TFDP2 mRNA | CTD | PMID:16129123 |
| choline | multiple interactions | ISO | RGD:1552301 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of TFDP2 mRNA | CTD | PMID:20938992 |
| cisplatin | decreases expression | EXP | | 6480464 | Cisplatin results in decreased expression of TFDP2 mRNA | CTD | PMID:22023808 |
| cobalt dichloride | increases expression | ISO | RGD:1314075 | 6480464 | cobaltous chloride results in increased expression of TFDP2 mRNA | CTD | PMID:19320972 |
| cocaine | increases expression | EXP | | 6480464 | Cocaine results in increased expression of TFDP2 mRNA | CTD | PMID:17898221 |
| copper(II) chloride | affects expression | ISO | RGD:1314075 | 6480464 | cupric chloride affects the expression of TFDP2 mRNA | CTD | PMID:17211630 |
| diazoxide | increases expression | ISO | RGD:1552301 | 6480464 | Isoproterenol results in increased expression of TFDP2 mRNA | CTD | PMID:20003209 |
| dibutyl phthalate | increases expression | ISO | RGD:1552301 | 6480464 | Dibutyl Phthalate results in increased expression of TFDP2 mRNA | CTD | PMID:21266533 |
| dibutyl phthalate | increases expression | ISO | RGD:1552301 | 6480464 | Dibutyl Phthalate results in increased expression of TFDP2 mRNA | CTD | PMID:17361019 PMID:21266533 |
| diethylstilbestrol | decreases expression | EXP | | 6480464 | Diethylstilbestrol results in decreased expression of TFDP2 mRNA | CTD | PMID:21658437 |
| dioxygen | multiple interactions | ISO | RGD:1552301 | 6480464 | Oxygen inhibits the reaction [Oxygen deficiency results in increased expression of TFDP2 mRNA] | CTD | PMID:22629407 |
| dioxygen | increases expression | ISO | RGD:1552301 | 6480464 | Oxygen deficiency results in increased expression of TFDP2 mRNA | CTD | PMID:22629407 |
| folic acid | multiple interactions | ISO | RGD:1552301 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of TFDP2 mRNA | CTD | PMID:20938992 |
| isoprenaline | increases expression | ISO | RGD:1552301 | 6480464 | Isoproterenol results in increased expression of TFDP2 mRNA | CTD | PMID:20003209 |
| isotretinoin | decreases expression | ISO | RGD:1314075 | 6480464 | Isotretinoin results in decreased expression of TFDP2 mRNA | CTD | PMID:20436886 |
| L-methionine | multiple interactions | ISO | RGD:1552301 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of TFDP2 mRNA | CTD | PMID:20938992 |
| N(6)-dimethylallyladenine | decreases expression | ISO | RGD:1314075 | 6480464 | N(6)-(delta(2)-isopentenyl)adenine results in decreased expression of TFDP2 mRNA | CTD | PMID:16129123 |
| phenobarbital | multiple interactions | ISO | RGD:1552301 | 6480464 | NR1I3 protein affects the reaction [Phenobarbital results in decreased expression of TFDP2 mRNA] | CTD | PMID:19482888 |
| phenobarbital | decreases expression | ISO | RGD:1552301 | 6480464 | Phenobarbital results in decreased expression of TFDP2 mRNA | CTD | PMID:19482888 |
| quercetin | decreases expression | ISO | RGD:1314075 | 6480464 | Quercetin results in decreased expression of TFDP2 mRNA | CTD | PMID:21632981 |
| silver(1+) nitrate | increases expression | ISO | RGD:1314075 | 6480464 | Silver Nitrate analog results in increased expression of TFDP2 mRNA | CTD | PMID:22831968 |
| succimer | multiple interactions | ISO | RGD:1552301 | 6480464 | [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of TFDP2 mRNA | CTD | PMID:21641980 |
| tamibarotene | decreases expression | ISO | RGD:1314075 | 6480464 | Am 80 results in decreased expression of TFDP2 mRNA; more ... | CTD | PMID:15498508 |
| tamoxifen | increases expression | ISO | RGD:1314075 | 6480464 | Tamoxifen results in increased expression of TFDP2 mRNA | CTD | PMID:15590111 |
| tetrachloromethane | affects expression | ISO | RGD:1552301 | 6480464 | Carbon Tetrachloride affects the expression of TFDP2 mRNA | CTD | PMID:17484886 |